NCT05104567 A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) Status COMPLETED Phase PHASE2
NCT05101616 A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer Status SUSPENDED Phase PHASE1/PHASE2
NCT05100446 Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection Status UNKNOWN Phase EARLY_PHASE1
NCT05095636 Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer Status UNKNOWN Phase PHASE2
NCT05076279 Safety and Efficacy of Single or Reduced Ports Laparoscopic Gastrectomy for Advanced Gastric Cancer (SPACE-01) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05075993 Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05075421 Prognostic Values of Inflammation-based Indices in Gastric Cancer Status COMPLETED Phase N/A
NCT05070247 A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT05068635 Evaluation of the Efficacy of Distal Gastrectomy for the Treatment of Gastric Cancer (a Case Series) Status COMPLETED Phase N/A
NCT05057013 A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05052931 Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer Status UNKNOWN Phase PHASE2
NCT05052801 Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression Status COMPLETED Phase PHASE3
NCT05051423 "Mechanisms and Biomarkers of Response and Resistance to Current Targeted Therapies in Gastric Cancer" (THERRES) Status UNKNOWN Phase N/A
NCT05043987 Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers Status WITHDRAWN Phase PHASE1
NCT05039333 Clinical Study to Prove Safety and Effectiveness When Applying RUS™ Surgical Navigation Status UNKNOWN Phase N/A